129 related articles for article (PubMed ID: 38533637)
1. Improvement of lower urinary tract dysfunction by a monoacylglycerol lipase inhibitor in mice with spinal cord injury.
Cho KJ; Hashimoto M; Karnup S; Matsuoka K; Kamijo T; Kim JC; Koh JS; Yoshimura N
Neurourol Urodyn; 2024 Jun; 43(5):1207-1216. PubMed ID: 38533637
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent progression of neurogenic lower urinary tract dysfunction after spinal cord injury in the mouse model.
Saito T; Gotoh D; Wada N; Tyagi P; Minagawa T; Ogawa T; Ishizuka O; Yoshimura N
Am J Physiol Renal Physiol; 2021 Jul; 321(1):F26-F32. PubMed ID: 33969698
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new β3-adrenoceptor agonist, vibegron, on neurogenic bladder dysfunction and remodeling in mice with spinal cord injury.
Gotoh D; Shimizu N; Wada N; Kadekawa K; Saito T; Mizoguchi S; Morizawa Y; Hori S; Miyake M; Torimoto K; de Groat WC; Fujimoto K; Yoshimura N
Neurourol Urodyn; 2020 Nov; 39(8):2120-2127. PubMed ID: 32816344
[TBL] [Abstract][Full Text] [Related]
5. TRPA1 receptor modulation attenuates bladder overactivity induced by spinal cord injury.
Andrade EL; Forner S; Bento AF; Leite DF; Dias MA; Leal PC; Koepp J; Calixto JB
Am J Physiol Renal Physiol; 2011 May; 300(5):F1223-34. PubMed ID: 21367919
[TBL] [Abstract][Full Text] [Related]
6. The effect of neutralization of nerve growth factor (NGF) on bladder and urethral dysfunction in mice with spinal cord injury.
Wada N; Shimizu T; Shimizu N; de Groat WC; Kanai AJ; Tyagi P; Kakizaki H; Yoshimura N
Neurourol Urodyn; 2018 Aug; 37(6):1889-1896. PubMed ID: 29516546
[TBL] [Abstract][Full Text] [Related]
7. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
8. Role of p38 MAP kinase signaling pathways in storage and voiding dysfunction in mice with spinal cord injury.
Shimizu N; Wada N; Shimizu T; Suzuki T; Kurobe M; Kanai AJ; de Groat WC; Hashimoto M; Hirayama A; Uemura H; Yoshimura N
Neurourol Urodyn; 2020 Jan; 39(1):108-115. PubMed ID: 31579964
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver.
Habib A; Chokr D; Wan J; Hegde P; Mabire M; Siebert M; Ribeiro-Parenti L; Le Gall M; Lettéron P; Pilard N; Mansouri A; Brouillet A; Tardelli M; Weiss E; Le Faouder P; Guillou H; Cravatt BF; Moreau R; Trauner M; Lotersztajn S
Gut; 2019 Mar; 68(3):522-532. PubMed ID: 30301768
[TBL] [Abstract][Full Text] [Related]
10. The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.
Wilkerson JL; Niphakis MJ; Grim TW; Mustafa MA; Abdullah RA; Poklis JL; Dewey WL; Akbarali H; Banks ML; Wise LE; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2016 Apr; 357(1):145-56. PubMed ID: 26791602
[TBL] [Abstract][Full Text] [Related]
11. Antifibrosis treatment by inhibition of VEGF, FGF, and PDGF receptors improves bladder wall remodeling and detrusor overactivity in association with modulation of C-fiber afferent activity in mice with spinal cord injury.
Kwon J; Lee EJ; Cho HJ; Jang JA; Han MS; Kwak E; Kim H; An J; Park D; Han S; Shimizu N; Suzuki T; Takaoka EI; Yoshimura N
Neurourol Urodyn; 2021 Aug; 40(6):1460-1469. PubMed ID: 34015154
[TBL] [Abstract][Full Text] [Related]
12. Combinational effects of muscarinic receptor inhibition and β3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinal cord injury.
Wada N; Shimizu T; Takai S; Shimizu N; Tyagi P; Kakizaki H; Yoshimura N
Neurourol Urodyn; 2017 Apr; 36(4):1039-1045. PubMed ID: 27367752
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of a soluble guanylate cyclase activator, BAY 60-2770, on lower urinary tract dysfunction in mice with spinal cord injury.
Gotoh D; Saito T; Karnup S; Morizawa Y; Hori S; Nakai Y; Miyake M; Torimoto K; Fujimoto K; Yoshimura N
Am J Physiol Renal Physiol; 2022 Oct; 323(4):F447-F454. PubMed ID: 35952343
[TBL] [Abstract][Full Text] [Related]
14. The early, long-term inhibition of brain-derived neurotrophic factor improves voiding, and storage dysfunctions in mice with spinal cord injury.
Wada N; Yoshimura N; Kurobe M; Saito T; Tyagi P; Kakizaki H
Neurourol Urodyn; 2020 Jun; 39(5):1345-1354. PubMed ID: 32394603
[TBL] [Abstract][Full Text] [Related]
15. Post-injury bladder management strategy influences lower urinary tract dysfunction in the mouse model of spinal cord injury.
Wada N; Shimizu T; Takai S; Shimizu N; Kanai AJ; Tyagi P; Kakizaki H; Yoshimura N
Neurourol Urodyn; 2017 Jun; 36(5):1301-1305. PubMed ID: 27778376
[TBL] [Abstract][Full Text] [Related]
16. The Novel Monoacylglycerol Lipase Inhibitor MJN110 Suppresses Neuroinflammation, Normalizes Synaptic Composition and Improves Behavioral Performance in the Repetitive Traumatic Brain Injury Mouse Model.
Selvaraj P; Tanaka M; Wen J; Zhang Y
Cells; 2021 Dec; 10(12):. PubMed ID: 34943962
[TBL] [Abstract][Full Text] [Related]
17. Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice.
Ignatowska-Jankowska B; Wilkerson JL; Mustafa M; Abdullah R; Niphakis M; Wiley JL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2015 May; 353(2):424-32. PubMed ID: 25762694
[TBL] [Abstract][Full Text] [Related]
18. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
[TBL] [Abstract][Full Text] [Related]
19. WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms.
Wen J; Jones M; Tanaka M; Selvaraj P; Symes AJ; Cox B; Zhang Y
J Neuroinflammation; 2018 Jan; 15(1):9. PubMed ID: 29310667
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in Experimental Ischemic Stroke.
Choi SH; Arai AL; Mou Y; Kang B; Yen CC; Hallenbeck J; Silva AC
Stroke; 2018 Mar; 49(3):718-726. PubMed ID: 29440474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
